The overarching goal of the Mount Sinai Pathogen Surveillance Program (MS-PSP) is to improve patient outcomes through the detection, tracking and prevention of pathogen-related infections throughout the patient population at the Mount Sinai Health System. The Mount Sinai Health System is the largest hospital network in New York City, spanning eight hospitals and 400 ambulatory clinics.
The MS-PSP is co-directed by Drs. van Bakel (Genetics and Genomic Sciences), Sordillo (Clinical and Medical Microbiology Laboratories), and Simon (Microbiology). Team members and groups included: Drs. Sordillo, Paniz-Mondolfi, Ramirez-Gonzalez, and Gitman (Medical Microbiology Laboratories), Simon (Microbiology), Sebra (Genomics Core Facility), Nirenberg, Mahmood, Gai, Masters, Xiang, Rabin, Bose, Green, and Kovatch (Scientific Computing and Data)…
Read the full article here.
